Beijing Bohui Innovation Biotechnology Group Co., Ltd. (SHE:300318)

China flag China · Delayed Price · Currency is CNY
6.20
+0.13 (2.14%)
At close: Mar 6, 2026
Market Cap5.06B +6.9%
Revenue (ttm)834.38M -5.8%
Net Income-48.09M
EPS-0.06
Shares Out816.90M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume8,627,964
Average Volume14,555,785
Open6.07
Previous Close6.07
Day's Range6.03 - 6.20
52-Week Range5.29 - 8.63
Beta-0.12
RSI44.12
Earnings DateApr 25, 2026

About SHE:300318

Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of diagnostic products in China. The company offers human immunoglobulin for rabies, tetanus, hepatitis B, and intravenous injections; albumin; human prothrombin complex; and vaccine for rabies. It also provides molecular platform, such as Automatic Real-time Fluorescent Nucleic Acid Cartridge Analyzer(BHQ-III), and GenPlex BHF-VI Nucleic Acid Chip Analyzer; Trace Element Analyzers; Fluorescence Immunoassay An... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 2,179
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300318
Full Company Profile

Financial Performance

Financial Statements